P&G Health announced that the Goa plant will discontinue production of injections

On Wednesday, Procter & Gamble Health announced that from September 30, it would discontinue producing injections at its Goa manufacturing plant.

The company stated that it intends to source the injection portfolio of its goods from a contract manufacturer while also discontinuing the production of injections at the plant.

"Discontinuation of production at company’s plant in Goa, shall not have an impact on the continuity of sale of injections by the company, as the products will be sourced from a contract manufacturer," Procter & Gamble Health said in a filing to the stock exchanges.

To save costs and optimize supply, the company is outsourcing the manufacture of its injection portfolio.